Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
出版年份 2017 全文链接
标题
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
作者
关键词
-
出版物
Cell Death & Disease
Volume 8, Issue 2, Pages e2592-e2592
出版商
Springer Nature
发表日期
2017-02-02
DOI
10.1038/cddis.2017.30
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hypoxic tumor microenvironment: Opportunities to develop targeted therapies
- (2016) Akhil Patel et al. BIOTECHNOLOGY ADVANCES
- Malignant pleural mesothelioma: an update on diagnosis and treatment options
- (2016) Sanjana Kondola et al. Therapeutic Advances in Respiratory Disease
- Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions
- (2015) Eduard Badarau et al. CHEMISTRY & BIOLOGY
- Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT
- (2015) Roslyn J. Francis et al. LUNG CANCER
- Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden
- (2015) Clare Gilham et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- The Clinical Significance of Hypoxia in Human Cancers
- (2015) Neesha Dhani et al. SEMINARS IN NUCLEAR MEDICINE
- Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells
- (2015) Arcangela G. Manente et al. Oncotarget
- Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
- (2015) Matthew L. Fisher et al. Oncotarget
- Systemic therapy options for malignant pleural mesothelioma beyond first-line therapy: a systematic review
- (2015) Omar Abdel-Rahman et al. Expert Review of Respiratory Medicine
- HIF-1 Signaling in Drug Resistance to Chemotherapy
- (2014) N.A. Warfel et al. CURRENT MEDICINAL CHEMISTRY
- Transglutaminase Regulation of Cell Function
- (2014) Richard L. Eckert et al. PHYSIOLOGICAL REVIEWS
- Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
- (2013) Eduard Badarau et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2013) Jae-Heon Jeong et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence
- (2013) Jasmeet Assi et al. PLoS One
- Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
- (2012) T. W. H. Meijer et al. CLINICAL CANCER RESEARCH
- Passing the baton: the HIF switch
- (2012) Mei Yee Koh et al. TRENDS IN BIOCHEMICAL SCIENCES
- Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy
- (2012) Yen T. Phung et al. Journal of Cancer
- Tissue transglutaminase: a new target to reverse cancer drug resistance
- (2011) Alfredo Budillon et al. AMINO ACIDS
- Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer
- (2011) V. M. Phatak et al. AMINO ACIDS
- TG2, a novel extracellular protein with multiple functions
- (2011) Zhuo Wang et al. AMINO ACIDS
- Transglutaminase 2: A molecular Swiss army knife
- (2011) Soner Gundemir et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Hypoxia-Associated Factor Switches Cells from HIF-1 - to HIF-2 -Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion
- (2011) M. Y. Koh et al. CANCER RESEARCH
- Targeting Ovarian Tumor Cell Adhesion Mediated by Tissue Transglutaminase
- (2011) M. Khanna et al. MOLECULAR CANCER THERAPEUTICS
- The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26
- (2010) Panayiotis Kotsakis et al. AMINO ACIDS
- RGD-independent Cell Adhesion via a Tissue Transglutaminase-Fibronectin Matrix Promotes Fibronectin Fibril Deposition and Requires Syndecan-4/2 and α5β1 Integrin Co-signaling
- (2010) Zhuo Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HIF-1: upstream and downstream of cancer metabolism
- (2009) Gregg L Semenza CURRENT OPINION IN GENETICS & DEVELOPMENT
- Malignant Pleural Mesothelioma
- (2009) Anne S. Tsao et al. JOURNAL OF CLINICAL ONCOLOGY
- ERK activation and cell growth require CaM kinases in MCF-7 breast cancer cells
- (2009) John M. Schmitt et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells
- (2009) G -Y Jang et al. ONCOGENE
- Synthesis of potent water-soluble tissue transglutaminase inhibitors
- (2008) Martin Griffin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer
- (2008) A. Verma et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now